Crystallographic studies of retroviral intasome complexes

逆转录病毒嵌体复合物的晶体学研究

基本信息

  • 批准号:
    8919420
  • 负责人:
  • 金额:
    $ 41.82万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-09-01 至 2017-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Retrovirus integration is catalyzed by the viral integrase (IN), which forms a tetrameric complex with both ends of the linear viral DNA genome and captures a cellular target DNA for concerted insertions of the viral DNA termini. The IN-DNA complex formed by HIV-1 IN is the target of a class of antiviral drugs called IN strand- transfer inhibitors. A better understanding of the IN-DNA interactions is therefore important for improving the clinically relevant anti-HIV drugs as well as designing next-generation IN inhibitors. The recent success in the structural studies of prototype foamy virus (PFV) IN-DNA complexes led to tremendous amount of insights into the retrovirus integration reaction. However, structural characterization of IN-DNA complexes from any other retrovirus systems by X-ray crystallography has remained elusive, leaving open the question as to how well the architecture of the IN-DNA complexes is conserved between distantly related retrovirus systems. We hypothesize that domain arrangement and IN-DNA interactions within the intasome, a nucleoprotein complex containing the tetramer of IN with the viral and target DNA molecules, are different between the canonical 3- domain IN including HIV-1 IN and the larger 4-domain PFV IN featuring an additional DNA-binding domain and longer inter-domain linkers. To address this hypothesis, we will determine crystal structures of the intasome complexes formed by the canonical 3-domain retroviral INs. Using a novel approach we have developed, crystals of the Rous sarcoma virus intasome suitable for structure determination have been obtained. We will further use our technique to pursue the crystal structure of a lentiviral intasome bound to the host co-factor LEDGF/p75. Our X-ray crystallographic analyses will provide the critically needed structural information to better understand the integration of HIV-1 and closely related retroviruses.
描述(由申请方提供):逆转录病毒整合由病毒整合酶(IN)催化,其与线性病毒DNA基因组的两端形成四聚体复合物,并捕获细胞靶DNA以协同插入病毒DNA末端。由HIV-1 IN形成的IN-DNA复合物是一类称为IN链转移抑制剂的抗病毒药物的靶标。因此,更好地理解IN-DNA相互作用对于改进临床相关的抗HIV药物以及设计下一代IN抑制剂是重要的。最近在原型泡沫病毒(PFV)IN-DNA复合物的结构研究中的成功导致了对逆转录病毒整合反应的大量见解。然而,通过X射线晶体学对来自任何其他逆转录病毒系统的IN-DNA复合物的结构表征仍然是难以捉摸的,留下了关于IN-DNA复合物的结构在远亲逆转录病毒系统之间如何保守的问题。我们假设,结构域的安排和IN-DNA相互作用内的整合体,一个核蛋白复合物含有四聚体的IN与病毒和靶DNA分子,是不同的典型的3-域IN,包括HIV-1 IN和更大的4-域PFV IN具有额外的DNA结合域和更长的域间连接。为了解决这一假设,我们将确定晶体结构的整合体复合物形成的典型的3-域逆转录病毒INs. Using一种新的方法,我们已经开发出,晶体的劳斯肉瘤病毒整合体适合于结构测定。我们将进一步使用我们的技术来研究与宿主辅因子LEDGF/p75结合的慢病毒整合体的晶体结构。我们的X射线晶体学分析将提供急需的结构信息,以更好地了解HIV-1和密切相关的逆转录病毒的整合。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A C-terminal "Tail" Region in the Rous Sarcoma Virus Integrase Provides High Plasticity of Functional Integrase Oligomerization during Intasome Assembly.
劳斯肉瘤病毒整合酶中的 C 端“尾部”区域在整合体组装过程中提供了功能性整合酶寡聚化的高可塑性。
  • DOI:
    10.1074/jbc.m116.773382
  • 发表时间:
    2017
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Pandey,KrishanK;Bera,Sibes;Shi,Ke;Aihara,Hideki;Grandgenett,DuaneP
  • 通讯作者:
    Grandgenett,DuaneP
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Hideki Aihara其他文献

Hideki Aihara的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Hideki Aihara', 18)}}的其他基金

Project 4: Nuclease Inhibitors for Viruses of Pandemic Concern
项目 4:针对流行病病毒的核酸酶抑制剂
  • 批准号:
    10522813
  • 财政年份:
    2022
  • 资助金额:
    $ 41.82万
  • 项目类别:
PROJECT 3
项目3
  • 批准号:
    9804093
  • 财政年份:
    2019
  • 资助金额:
    $ 41.82万
  • 项目类别:
PROJECT 3
项目3
  • 批准号:
    10225391
  • 财政年份:
    2019
  • 资助金额:
    $ 41.82万
  • 项目类别:
PROJECT 3
项目3
  • 批准号:
    10474982
  • 财政年份:
    2019
  • 资助金额:
    $ 41.82万
  • 项目类别:
Structural studies of viral replication and invasion
病毒复制和侵袭的结构研究
  • 批准号:
    10337889
  • 财政年份:
    2016
  • 资助金额:
    $ 41.82万
  • 项目类别:
APOBEC3 STRUCTURAL STUDIES
APOBEC3 结构研究
  • 批准号:
    9332852
  • 财政年份:
    2016
  • 资助金额:
    $ 41.82万
  • 项目类别:
APOBEC3 STRUCTURAL STUDIES
APOBEC3 结构研究
  • 批准号:
    9726634
  • 财政年份:
    2016
  • 资助金额:
    $ 41.82万
  • 项目类别:
Structural studies of DNA-processing enzymes
DNA 加工酶的结构研究
  • 批准号:
    9307881
  • 财政年份:
    2016
  • 资助金额:
    $ 41.82万
  • 项目类别:
Structural studies of viral replication and invasion
病毒复制和侵袭的结构研究
  • 批准号:
    10544179
  • 财政年份:
    2016
  • 资助金额:
    $ 41.82万
  • 项目类别:
Structural studies of DNA-processing enzymes
DNA 加工酶的结构研究
  • 批准号:
    9070069
  • 财政年份:
    2016
  • 资助金额:
    $ 41.82万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 41.82万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 41.82万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.82万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.82万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 41.82万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.82万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 41.82万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 41.82万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 41.82万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.82万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了